Arizeke Pharmaceuticals Overview

  • Founded
  • 1997
  • Status
  • Private
  • Latest Deal Type
  • Undetermined

Arizeke Pharmaceuticals General Information


Developer of technologies for oral delivery of macromolecules. The company's technology takes advantage of an active transport system, using the polymeric immunoglobulin receptor (pIgR) highly expressed in the intestinal and lung epithelium, and enables delivery of macromolecules such as therapeutic proteins and antibodies via oral or nasal administration.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Drug Delivery
Primary Office
  • 6828 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arizeke Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Undetermined 000.00 Completed
2. Later Stage VC 01-Jan-2004 000.00 Completed Generating Revenue
1. Later Stage VC (Series C) 01-May-2001 $16.8M $16.8M Completed Generating Revenue
To view Arizeke Pharmaceuticals’s complete valuation and funding history, request access »